Figure 4

Experimentally observed antileishmanial activity values (pIC50 (observed)) versus calculated activity values (pIC50 (calculated)), using Eq. 1, for the 17 quinoxaline derivatives in the training set (after removing outlier 4b).
Experimentally observed antileishmanial activity values (pIC50 (observed)) versus calculated activity values (pIC50 (calculated)), using Eq. 1, for the 17 quinoxaline derivatives in the training set (after removing outlier 4b).